Global Site
Breadcrumb navigation
NEC Global Topics
- July 27, 2023
-
[NEC Laboratories Europe Press Releases]
NEC laboratories advances therapeutic cancer vaccine research with new AI model Attentive Variational Information Bottleneck
- March 23, 2023
-
[NEC Laboratories Europe Press Releases]
Unikraft, a NEC Laboratories Europe spin-off, raises European and U.S. venture capital and begins operation as an independent company
- April 6, 2022
-
[NEC Laboratories India Press Release]
NEC Laboratories India & Tamil Nadu Agricultural University sign MoU to co-create newer agri-tech solutions to improve agri output
- February 7, 2022
-
[NEC Laboratories Europe Web update]
Biomedical AI Advancing medicine through the power of AI
- January 25, 2022
-
[NEC Laboratories Europe Press Releases]
NEC Laboratories Europe achieves breakthrough in smart surface technology for 5G and beyond wireless connectivity
- December 21, 2021
-
[NEC Laboratories Europe Publications]
D. Friede, M. Niepert: “Efficient Learning of Discrete-Continuous Computations Graphs”, Conference on Neural Information Processing Systems (NeurIPS) 2021
M. Niepert, Minervini Pasquale, Luca Franceschi: “Implicit MLE: Backpropagating Through Discrete Exponential Family Distributions”, Conference on Neural Information Processing Systems (NeurIPS) 2021
- November 23,021
-
[NEC Laboratories Europe Press Releases]
Transgene and NEC announce positive preliminary data from Phase I studies of TG4050, a novel individualized neoantigen cancer vaccine
- May 12, 2021
-
[NEC Laboratories Europe Press Releases]
NEC Laboratories Europe supports InHANSE innovative clinical cancer research
- March 30, 2021
-
[NEC Laboratories Europe Press Releases]
Building Beyond 5G systems with NEC technology for next-generation mobile services
- March 24,021
-
[NEC Laboratories Europe Press Releases]
Lifesaving NEC drone technology quickly locates missing natural disaster victims by mobile phone